Renee Greer

Renee Greer is a biomedical scientist specializing in pharmacology, pharmacokinetics, and toxicology, with a focus on preclinical drug development in oncology and immunology. Currently serving as an Immunology Lead at Biogen, Renee previously held positions as Principal Scientist at Asher Biotherapeutics, where they led a product development team and managed multiple studies to generate preclinical data for IND submissions. With a Ph.D. in Biomedical Science from the University of California, San Francisco, Renee has contributed significantly to scientific literature and has experience in project leadership, decision-making, and stakeholder communication throughout the drug development process.